Evidence map›Paper›PMID 35101060›Full record

ArticleConflict and health2022

Cancer among syrian refugees living in Konya Province, Turkey.

Tezer Kutluk, Mehmet Koç, İrem Öner, İbrahim Babalıoğlu, Meral Kirazlı, Sinem Aydın, Fahad Ahmed, Yavuz Köksal, Hüseyin Tokgöz, Mustafa Duran and 1 more

Open access · goldAbstract read
In one paragraph

Article in Conflict and health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Tezer KutlukDepartment of Pediatric Oncology, Hacettepe University Faculty of Medicine and Cancer Institute, 06100, Ankara, Turkey. tezerkutluk@gmail.com.ORCID http://orcid.org/0000-0002-1918-4407
Mehmet KoçProvincial Directorate of Health Konya, Konya, Turkey.
İrem ÖnerMedical Oncology Unit, Ministry of Health City Hospital, Konya, Turkey.
İbrahim BabalıoğluRadiation Oncology Unit, Ministry of Health City Hospital, Konya, Turkey.
Meral KirazlıDepartment of Pediatric Oncology, Hacettepe University Faculty of Medicine and Cancer Institute, 06100, Ankara, Turkey.
Sinem AydınDepartment of Pediatric Oncology, Hacettepe University Faculty of Medicine and Cancer Institute, 06100, Ankara, Turkey.
Fahad AhmedDepartment of Pediatric Oncology, Hacettepe University Faculty of Medicine and Cancer Institute, 06100, Ankara, Turkey.
Yavuz KöksalDepartment of Pediatric Oncology, Selçuk University Meram Faculty of Medicine, Konya, Turkey.
Hüseyin TokgözDepartment of Pediatric Hematology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey.
Mustafa DuranHematology Unit, Ministry of Health City Hospital, Konya, Turkey.
Richard SullivanInstitute of Cancer Policy, Conflict and Health Research Group, King's College London, London, UK.
Hacettepe University · TRMinistry of Health · TRKing's College London · GBNecmettin Erbakan University · TRSelçuk University · TR

Funding

National Institute of Health Research Project No131207UK Research and Innovation GCRF Research for Health in Conflict (R4HC-MENA)</ R4HC MENA (ES/P010962/1)
6 · The paper itself

Abstract

backgroundWith more than 3.6 million Syrian refugees Turkey hosts the world's largest number of Syrians. Considering the morbidity, mortality, and healthcare spending, cancer is one of the leading health and economic burden for patients and healthcare systems. However, very limited information available in the scientific literature to understand the burden and characteristics of cancer in countries hosting Syrian refugees. The aim of the present study is to evaluate the demographic and clinical characteristics, treatment outcome of Syrian cancer patients living in Konya, Turkey.

methodsWe retrospectively reviewed medical records of Syrian cancer patients at three major institutions from 2005 to 2020. The information regarding demographic and clinical characteristics of patients were identified. The number of days between the first symptom and diagnosis was considered as the "diagnostic interval". Patients who failed to attend clinics within four weeks of appointment were assumed abandoned treatment. Survival curves were estimated using the Kaplan-Meier method.

resultsWe identified 230 adult and 38 children refugee diagnosed with cancer during the study period. With regards to adult patients, there were 114 (49.6%) male and 116 (50.4%) female. The median age at diagnosis was 52.4, 47.3 years for male, female respectively. The five most common cancer by site among all were; breast (24.8%), colorectal (10.9%), lung (7.4%), central nervous system (CNS) (7.0%), and stomach (5.2%). 93 (40.4%) had metastatic disease at diagnosis. The overall survival probability was 37.5% at five years for the adult population. Data were extracted for 20 boys and 18 girls with childhood cancer. Their median age at diagnosis was 5.8 and 6.0 years respectively. The three most common childhood cancer were; leukemias (21.1%), lymphomas (21.1%), and CNS (13.2%). Excluding leukemia, 13 (43.3%) of childhood cancer cases had the advanced disease at diagnosis. Three year survival probality was 69.5%. The median diagnostic interval for adult and childhood cancer was 96.5 (IQR = 53-165) and 23 (IQR = 13.5-59) days respectively. Twenty-one adults and four children had treatment abandonment.

conclusionThis study contributes to understanding the burden of cancer among Syrian refugees living in Konya, growing health issue for refugees. Larger and prospective studies will help to measure the real burden and compare the difference in cancer risk factors, care, and outcomes among the refugee and host populations.

Indexed as

CancerSyrian refugees

Identifiers

PMID35101060
PMCPMC8805424
OpenAlexW4210408260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.